The mechanism appears to involve increased fat metabolism and reduced fat accumulation, potentially through AMPK activation
Given that retatrutide already activates three receptor pathways, the marginal benefit of adding additional GLP-1 or GIP agonists is likely minimal or counterproductive
Retatrutide targets three receptor pathways (GLP-1, GIP, and glucagon) compared to semaglutide targeting only GLP-1
If experiencing severe gastrointestinal symptoms, maintain adequate hydration to prevent dehydration and potential acute kidney injury
A beneficiary with a BMI of 32 and uncontrolled hypertension, or a BMI of 28 with pre-diabetes and a prior stroke, previously had no straightforward path to GLP-1 coverage
and the right to request confidential communications